Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Arthritis Care & Research
|
February 16, 2026
Treatment Sequencing and Line of Therapy for Biologics and JAK inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Predictive Biomarker Diagnostics
Jeffrey R Curtis, Shanette Daigle, Emily E Holladay, et al.
Frontiers in Immunology
|
February 27, 2024
Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development
Yi Wang, Matthew C Troutman, Carl Hofmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 20, 2020
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol
Zhao-Hua Zhou, Cosby A Stone, Baruch Jakubovic, et al.
Journal of Translational Autoimmunity
|
May 6, 2022
Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus
Christie Fanton, Richard Furie, Vishala Chindalore, et al.
The Journal of Rheumatology
|
April 16, 2022
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study
Tien Nguyen, Melvin Churchill, Robert Levin, et al.
Schizophrenia Bulletin
|
May 13, 2005
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
Robert W Buchanan, Miriam Davis, Donald Goff, et al.
Journal of Pharmaceutical Sciences
|
October 3, 2009
Topical delivery of lycopene using microemulsions: enhanced skin penetration and tissue antioxidant activity
Luciana B Lopes, Hillary VanDeWall, Hsin T Li, et al.
Integrative Cancer Therapies
|
November 21, 2009
Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms
William J M Hrushesky, James Grutsch, Patricia Wood, et al.
Annals of the Rheumatic Diseases
|
July 30, 2011
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
Joan T Merrill, Daniel J Wallace, Michelle Petri, et al.
Arthritis Research & Therapy
|
June 6, 2024
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
Stanley Cohen, Jean S Beebe, Vishala Chindalore, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Arthritis Care & Research
|
February 16, 2026
Treatment Sequencing and Line of Therapy for Biologics and JAK inhibitors in Rheumatoid Arthritis Patients: Implications for Design and Uptake of New Drugs and Predictive Biomarker Diagnostics
Jeffrey R Curtis, Shanette Daigle, Emily E Holladay, et al.
Frontiers in Immunology
|
February 27, 2024
Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development
Yi Wang, Matthew C Troutman, Carl Hofmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 20, 2020
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol
Zhao-Hua Zhou, Cosby A Stone, Baruch Jakubovic, et al.
Journal of Translational Autoimmunity
|
May 6, 2022
Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus
Christie Fanton, Richard Furie, Vishala Chindalore, et al.
The Journal of Rheumatology
|
April 16, 2022
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study
Tien Nguyen, Melvin Churchill, Robert Levin, et al.
Schizophrenia Bulletin
|
May 13, 2005
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
Robert W Buchanan, Miriam Davis, Donald Goff, et al.
Journal of Pharmaceutical Sciences
|
October 3, 2009
Topical delivery of lycopene using microemulsions: enhanced skin penetration and tissue antioxidant activity
Luciana B Lopes, Hillary VanDeWall, Hsin T Li, et al.
Integrative Cancer Therapies
|
November 21, 2009
Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms
William J M Hrushesky, James Grutsch, Patricia Wood, et al.
Annals of the Rheumatic Diseases
|
July 30, 2011
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
Joan T Merrill, Daniel J Wallace, Michelle Petri, et al.
Arthritis Research & Therapy
|
June 6, 2024
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
Stanley Cohen, Jean S Beebe, Vishala Chindalore, et al.
Page
of 6